West Family Investments Inc. purchased a new stake in Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) during the fourth quarter, according to its most recent filing with the SEC. The fund purchased 4,678 shares of the financial services provider’s stock, valued at approximately $868,000.
Several other hedge funds and other institutional investors have also made changes to their positions in the stock. KERR FINANCIAL PLANNING Corp bought a new position in Marsh & McLennan Companies during the fourth quarter valued at approximately $27,000. City Holding Co. purchased a new stake in shares of Marsh & McLennan Companies during the 4th quarter worth approximately $29,000. Headlands Technologies LLC bought a new position in shares of Marsh & McLennan Companies during the 2nd quarter valued at approximately $29,000. Financial Life Planners purchased a new position in shares of Marsh & McLennan Companies in the third quarter valued at $32,000. Finally, Elyxium Wealth LLC bought a new stake in Marsh & McLennan Companies in the fourth quarter worth $34,000. Institutional investors own 87.99% of the company’s stock.
Marsh & McLennan Companies Trading Down 0.0%
Shares of NYSE:MRSH opened at $165.37 on Monday. The company has a debt-to-equity ratio of 1.28, a quick ratio of 1.11 and a current ratio of 1.11. The stock has a market cap of $79.89 billion, a P/E ratio of 20.67, a PEG ratio of 2.41 and a beta of 0.62. Marsh & McLennan Companies, Inc. has a 12 month low of $156.60 and a 12 month high of $231.36.
Insider Buying and Selling at Marsh & McLennan Companies
In related news, CEO John Q. Doyle sold 16,656 shares of the business’s stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total value of $2,693,441.76. Following the completion of the sale, the chief executive officer owned 116,811 shares in the company, valued at approximately $18,889,506.81. The trade was a 12.48% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.38% of the company’s stock.
Analyst Ratings Changes
Several equities analysts have commented on MRSH shares. Citigroup upgraded shares of Marsh & McLennan Companies from a “neutral” rating to a “buy” rating and set a $200.00 price objective for the company in a research report on Wednesday, May 6th. JPMorgan Chase & Co. decreased their target price on shares of Marsh & McLennan Companies from $226.00 to $206.00 and set an “overweight” rating on the stock in a research report on Thursday, April 9th. Barclays dropped their price target on Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating for the company in a research report on Wednesday, April 8th. Piper Sandler decreased their price objective on Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 26th. Finally, Bank of America dropped their target price on Marsh & McLennan Companies from $181.00 to $174.00 and set an “underperform” rating for the company in a report on Tuesday, April 14th. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, ten have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Marsh & McLennan Companies presently has an average rating of “Hold” and a consensus price target of $203.56.
Check Out Our Latest Stock Analysis on Marsh & McLennan Companies
Marsh & McLennan Companies Company Profile
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Recommended Stories
- Five stocks we like better than Marsh & McLennan Companies
- The Market May Be Missing What’s Changing at BigBear AI
- These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?
- 3 Stocks Under $20 to Buy Before a Broader Market Rally
- Petco Faces Tough Competition, But Momentum Is Building
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
